Company profile for Genepharm S.A

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Since 1967 Genepharm S.A. has been committed to the development, manufacturing, marketing and distribution of generic pharmaceutical products. Genepharm's Product Development team delivers several new products every year, which are registered around the world by its in-house Regulatory team. Three separate state-of-the-art production facilities, designed in accordance with cGMP requirements, allow the company to manufacture a ...
Since 1967 Genepharm S.A. has been committed to the development, manufacturing, marketing and distribution of generic pharmaceutical products. Genepharm's Product Development team delivers several new products every year, which are registered around the world by its in-house Regulatory team. Three separate state-of-the-art production facilities, designed in accordance with cGMP requirements, allow the company to manufacture a wide range of conventional and oncology products, either under license or Genepharm's brand. Genepharm S.A. provides its products to many of the world's leading generic pharmaceutical companies.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
Greece
Address
Address
8km Marathon Avenue15351 Pallini, Greece
Telephone
Telephone
+30 210 603 9336
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

DCAT Week

DCAT Week

Not Confirmed

envelop Contact Supplier

DCAT Week

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more
MS Pharma acquires Genepharm, expands chronic disease portfolio
MS Pharma acquires Genepharm, expands chronic disease portfolio

23 Apr 2019

// Vassia Barba IN-PHARMANECHNOLOGIST

https://www.in-pharmatechnologist.com/Article/2019/04/23/MS-Pharma-acquires-Genepharm

Vassia Barba IN-PHARMANECHNOLOGIST
23 Apr 2019

https://www.prnewswire.com/news-releases/ms-pharma-announces-acquisition-of-genepharm-300832786.html

PR NEWSWIRE
16 Apr 2019

FDF Dossiers

read-more
read-more

01

Brand Name : Dutasteride / Tamsul...

Global ChemShow
Not Confirmed
arrow

Brand Name : Dutasteride / Tamsul...

arrow
Global ChemShow
Not Confirmed

Genepharm S.A

Dosage Form : Hard Capsule

Brand Name : Dutasteride / Tamsulosin ...

Dosage Strength : 0.5MG; 0.4MG

Packaging :

Approval Date : 2019-09-06

Application Number :

Regulatory Info : Authorised

Registration Country : Malta

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Europe

read-more
read-more

01

Brand Name : Dutasteride / Tamsul...

Global ChemShow
Not Confirmed
arrow

Brand Name : Dutasteride / Tamsul...

arrow
Global ChemShow
Not Confirmed

Genepharm S.A

Dosage Form : Hard Capsule

Dosage Strength : 0.5MG; 0.4MG

Packaging :

Brand Name : Dutasteride / Tamsulosin Gene...

Approval Date : 2019-09-06

Application Number :

Regulatory Info : Authorised

Registration Country : Malta

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Inspections and registrations

Upload your audits for free, ask us

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty